Zviitiko zvitsva mukurapa kenza yemazamu

Zvitsva zvitsva mukurapa kenza yemazamu zvinogamuchirwa zvakanaka muzvipatara zveIndia nepamusoro oncologists. Nhanho 3 & nhanho 4 kurapwa kenza yemazamu muIndia. Batanidza ne +91 96 1588 1588 kurapwa kwegomarara rezamu repamazamu zvakanakisa & zvine mari.

Share This Post

Kurapwa kwegomarara rezamu kwakafambira mberi nekukurumidza zvikuru mumakore mashoma apfuura uye pave nekuvandudzwa kutsva mukurapwa kwegomarara rezamu. Mukuru wekutsvagisa Dr Juha Klefstorm pa University of Helsinki uyo ari kushanda kwenguva yakareba mubasa rekutsvakurudza rine chokuita nekenza akawana kuti masero ekenza anogona kurwiswa ne "drug cocktail" iyo inosanganisira chirwere cheshuga metformin uye venetoclax, BCL-2 protein inhibitor inogona kukonzera apoptosis mumasero ekenza. . Chikwata chakaziva metformin mune scan yemishonga inogona kubatsira apoptosis -kuita chiitiko che venetoclax. Venetoclax yakagamuchirwa kurapa mamwe ma leukemias asi isati iri yekurapa kenza yemazamu.

"Mushonga uyu unokanganisa kukanganiswa kwemetabolism iyo yakawanda yeMYC inogadzira tumarara masero. Metformin uye venetoclax, kana yakapihwa pamwechete, yakauraya mazamu bundu maseru mutsika uye yakavharira kukura kwebundu muchipfuva chakashata chisikwa chekukura modhi. Zvakare, mishonga yacho yakanyatso kuuraya iyo fide yakashata yemazamu kukura tishu yakapihwa nevarwere vezamu. Ongororo dzechirwere chezamu dzakatorwa kubva mukurapwa kwakaitwa muHelsinki University Hospital,” Dr. Klefstrom anodaro.

Chero zvazvingava, vanamazvikokota vasati vamboona kuti metformin mukuwedzera kurapwa kwevenetoclax yaingochengeta mamota mukati memiganhu yakafanira chero bedzi mbeva dzine mabundu emuchipfuva akadzikwa dzichirapwa nemishonga; apo kurapwa kwakamira, mapundu akadzoka. Ongororo yacho inoratidza kuti mapundu pakutanga akatakurwa nebundu-kuuraya lymphocytes; zvisinei, mushure mekurapwa ivo vakanyangarika zvakanyanya uye mamwe masero emhondi akataurirana PD-1, chiratidzo chekuramba kupera kwesero.

Kugonesa maseru asingabatike kuti akwanise kurwisa bundu, nyanzvi dzakagadzira imwe nzira yekurapa. Kutanga, vanorova mazamu emazamu neapoptosis-actuating zvinodhaka metformin uye venetoclax kuderedza bvunzo dzebundu uye kumutsa vanouraya lymphocytes. Mushure mekunge mabundu akakosha anyatsodzingwa, mbeva dzakabva dzarapwa nemusanganiswa katatu: metformin, venetoclax uye PD-1-yakatarisana neanopikisa acting agent, iyo inoshandiswa muimmunotherapies kuchengetedza masero emhondi ane simba refu.

Kurapa kenza yemazamu - Dr Heidi Haikala

Muvambi mukuru weongororo iyi Dr Heidi Haikala anoona: venture. "Tine chivimbo pamusoro pezvatakatora uye tarisiro yekuti zvichareva mukana pachipfuva chinokuvadza chevarwere."

“Iyi inyaya isinganzwisisike yekuti vatsvagiri munyika yevadzidzi, vachishandisa mamota ane hunyanzvi uye vachishandisa ruzivo rwavo rwunoshamisa, vanogona kuwedzera mukuburitswa kwemishonga mitsva ingangowanikwa kune vanhu vane kukura kwakashata. Izvi zvinoratidzawo kutsvagisa kunoshamisa kuri kuitwa munyika diki dzakadai seFinland, ”anodaro Joel Leverson, Ph.D., Senior Scientific Director kuAbbVie uye mumwe wevagadziri vakuru mukuferefeta uku.

Tariro mumakore anotevera pachave nekumwe kusimukira mukurapwa kwe kenza yebonde

Kurapwa kwegomarara rezamu uye kuvhiyiwa batana nesu pa +91 96 1588 1588. Kana kuti email mishumo yako pa cancerfax@gmail.com kuti uwane maonero echipiri.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.
kenza

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.

Lutetium Lu 177 dotatate, kurapwa kwepasi, ichangobva kugamuchira mvumo kubva kuUS Food and Drug Administration (FDA) yevarwere vevana, zvichiratidza chiitiko chakakosha muvana oncology. Mvumo iyi inomiririra chiedza chetariro kuvana vari kurwisana neuroendocrine tumors (NETs), isingawanzowanikwi asi inonetsa yegomarara iro rinowanzoratidza kuti rinoshingirira pakurapa kwakajairika.

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.
Chirwere chechirwere

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.

"Nogapendekin Alfa Inbakicept-PMLN, chinyorwa che immunotherapy, chinoratidza vimbiso mukurapa gomarara redundira kana yasanganiswa neBCG therapy. Iyi nzira yekuvandudza yakanangana nemakaki egomarara uku ichisimudzira mhinduro ye immune system, ichiwedzera kushanda kwemishonga yechivanhu seBCG. Miedzo yemakiriniki inoratidza zvinokurudzira, zvichiratidza zvakavandudzwa mhedzisiro yemurwere uye kufambira mberi kunogona kuitika mukurapa kenza yedundira. Kuwirirana pakati peNogapendekin Alfa Inbakicept-PMLN neBCG kunozivisa nguva itsva mukurapa gomarara redundira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa